Annals of Dermatology (Ann Dermatol) is primarily intended for publication of work from contributors who are interested in clinical dermatology and laboratory researches on the skin, from all over the world and is expected to promote sincere communication among clinicians and researchers working in this field. The Journal will contain invited review articles (an average of 3,500 words), original articles (not exceeding 3,500 words), case reports (not exceeding 1,500 words), and brief reports (brief research reports: not exceeding 1,000 words, brief case reports: not exceeding 500 words). Ann Dermatol follows guidelines which are published by professional organizations, including Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals (http://www.icmje.org/icmje-recommendations.pdf) from ICMJE and Principles of Transparency and Best Practice in Scholarly Publishing (joint statement by COPE, DOAJ, WAME, and OASPA; (http://doaj.org/bestpractice). The journal reserves the right to reject any manuscript that does not meet the standards for publication. All the authors listed in the manuscript are assumed to have agreed to the following policy of Ann Dermatol on submission of manuscripts. Only previously unpublished manuscripts must be submitted to the Journal, and they should not be under consideration for publication elsewhere. The accepted manuscripts will become the property of Ann Dermatol and may not be published elsewhere without written permission from, both editor and publisher. If a new author has to be added or an existing author has to be deleted after submission, it is the responsibility of the corresponding author to ensure that the authors concerned are aware of and agree to the change in authorship. Ann Dermatol has no responsibility for such changes. The editors, publisher, Korean Dermatological Association, and Korean Society for Investigative Dermatology disclaim any responsibility for the statements and opinions in the articles and do not guarantee or endorse any product or service advertised in this publication. Ann Dermatol is published six times a year (February, April, June, August, October, and December, at the beginning of the month) in English by the Korean Dermatological Association and Korean Society for Investigative Dermatology.

Ann Dermatol is an open access journal. Accepted peer-reviewed articles are freely available on the journal website for any user, worldwide, immediately upon publication without additional charge. Articles are distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

- Non-commercial use (e.g., academic/educational purposes): Content may be used freely, provided the original source is fully cited.

- Commercial use (e.g., for-profit purposes): Prior written permission from the journal office is mandatory. Please download the required application form from [https://anndermatol.org/src/permission to reproduce_2025.docx] and send the completed form to the Journal Office email address (dermajournal@gmail.com) for review.

Ann Dermatol is owned by the publisher, the Korean Dermatological Association and the Korean Society of Investigative Dermatology.

Ann Dermatol had been published biannually since 1989 and quarterly since 1995. Since 2014, it is being published bimonthly.

Those who are involved in research of dermatological field with high activity and who have plenty of experiences as a reviewer or are qualified for editorial process are proper candidates for editors. Those who have qualification, for example certificate, or are proved to have academic achievements in dermatology or relevant field are preferred.

Editor-in-chief is renewed every 5 years.

Editor, Section editors and Editorial boards are renewed every 2 years.

Take charge of whole contents and process of the journal

Organize and manage editor, section editors and editorial board members

Make the final decision for any issue regarding publication

Assist editor-in-chief in process of reviewing, editing and publishing

Monitor the peer-review editorial process

Manage review and editing of submitted manuscripts in assigned subjects

Assign manuscripts for review to appropriate reviewers

Take charge of maintaining the ethical integrity of manuscript and review process

Administer the process of peer-review

Participate as a peer reviewer

Help the journal to attract manuscripts with high-quality

Provide scientific expertise and feedback for the journal

Edit accepted manuscript in a print version

Take charge of file conversion and publication process

Assist editor-in-chief and editor

Take charge of clerical work

Edit manuscripts, figures, tables

Cases that require editorial expressions of concern or retraction shall follow the COPE flowcharts available from http://publicationethics.org/resources/flowcharts. If correction is necessary, it will follow the ICMJE Recommendation for Corrections, Retractions, Republications and Version Control available form http://www.icmje.org/recommendations/browse/publishing-and-editorial-issues/corrections-and-version-control.html as follows:

Honest errors are a part of science and publishing and require publication of a correction when they are detected. Corrections are needed for errors of fact. Minimum standards are as follows: First, it shall publish a correction notice as soon as possible detailing changes from and citing the original publication on both an electronic and numbered print page that is included in an electronic or a print Table of Contents to ensure proper indexing; Second, it shall post a new article version with details of the changes from the original version and the date(s) on which the changes were made through CrossMark; Third, it shall archive all prior versions of the article. This archive can be either directly accessible to readers; Fourth, previous electronic versions shall prominently note that there are more recent versions of the article via CrossMark.

When the journal faces suspected cases of research and publication misconduct such as redundant (duplicate) publication, plagiarism, fraudulent or fabricated data, changes in authorship, an undisclosed conflict of interest, ethical problems with a submitted manuscript, a reviewer who has appropriated an author’s idea or data, and complaints against editors, the resolution process will follow the flowchart provided by the Committee on Publication Ethics (http://publicationethics.org/resources/flowcharts). The discussion and decision on the suspected cases are conducted by the Editorial Board.

If a published paper is subsequently found to have errors or major flaws, the editor should take responsibility for promptly correcting the written record in the journal. The specific content of the correction may address whether the errors originated with the author or journal. Originality, Prior Publication, and Media Relations Republication of a paper in another language, or simultaneous publication in multiple journals with different audiences may be acceptable, provided that there is full and prominent disclosure of its original source at the time of submission of the manuscript. At the time of submission, authors should disclose details of related papers they have authored, even if in a different language, similar papers in press, and any closely related papers previously published or currently under review in another journal. Previous publication of an abstract during the proceedings of meetings (in print or electronically) does not preclude subsequent submission for publication, but full disclosure should be made at the time of submission. For resolving cases of suspended misconduct, the journal follows the COPE Flowcharts (http://publicationethics.org/resources/flowcharts).

Ann Dermatol is accessible at KoreaMed (https://www.koreamed.org), Google scholar (https://scholar.google.co.kr) and National Library of Korea (http://nl.go.kr) in the event a journal is no longer published.

Revenue sources of Ann Dermatol include publication fee, support from publisher (the Korean dermatological association) and fund provided by government.

All advertisements and commercially sponsored publications are independent from editorial decisions. Ann Dermatol does not endorse any product or service marked as an advertisement or promoted by a sponsor in publications. Editorial content is not compromised by commercial or financial interests, or by any specific arrangements with advertising clients or sponsors. Ann Dermatol reserves the right to decline any type of advertising that is damaging to the brand of Ann Dermatol, and will not accept advertising for products or services known to be harmful to health (e.g. tobacco and alcohol products).

Advertisements may not be deceptive or misleading, and must be verifiable. Advertisements should clearly identify the advertiser and the product or service being offered. Exaggerated or extravagantly worded copy will not be allowed. Advertisements will not be accepted if they appear to be indecent or offensive in either text or artwork, or if they relate to content of a personal, racial, ethnic, sexual orientation, or religious nature.

Ann Dermatol will not allow any treatment-specific or drug-specific campaign to be targeted to a specific article(s) or on any page where content relates to the product(s) being advertised. (Advertisers may not link to articles using keywords; they may not target advertising for a specific product on the condition that it appear in the same location and at the same time as a specific article mentioning that product and they may not refer to an article published at the same time as the advertisement appears).

Editorial decisions will not be influenced by current or potential sponsors and advertisers, and will not be influenced by marketing decisions. Advertisers and sponsors have no control or influence over the results of searches a user may conduct on the website by keyword or search topic.

Journal propagation has been done through the journal website and distribution of an introduction pamphlet. Invitations to submit a manuscript are usually focused on the presenters at conferences, seminars, or workshops if the topic is related to the journal's aims and scope.

Ann Dermatol accepts papers submitted in not-for-profit preprint servers (e.g., arXiv, bioRxiv, MedRxiv, or similar platforms). Although the paper’s eligibility to Ann Dermatol will not be limited, its novelty may be undermined if the work is widely recognized through media or other means. Authors posting their preprint work in Ann Dermatol are required to disclose the following policies;